Vaccines for treatment of lymphoma and leukemia
CA 2248653 C · Owner: Genitope Corporation · Inventors: Denney, Dan W. Jr.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides multivalent vaccines for the treatment of Bcell malignancies (e.g. lymphomas and leukemias). The present invention also provides methods for the production of custom vaccines including multivalent , vaccines for the treatment of immune cell tumors malignancies as well as methods of treating immune cell tumors using custom vaccines. The present invention further provides improved methods for the amplification and expression of recombinant genes in cells. The methods of the present invention permit the isolation of cell lines which have co-amplified input recombinant sequences which encode an amplifiable marker one or more expression vectors , encoding a …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 25, 1997 and granted August 12, 2003. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended April 25, 2017.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 25, 2019.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.